DEF 14A: Crown Electrokinetics Seeks Stockholder Approval for Reverse Stock Split, Incentive Plan, and Equity Issuance

Crown Electrokinetics is asking stockholders to approve several key proposals at its upcoming annual meeting, including a reverse stock split, a new employee incentive plan, and the potential issuance of shares to an accredited investor.

Summary

• Crown Electrokinetics Corp. is holding its Annual Meeting of Stockholders on June 14, 2024, to vote on several proposals.
• The proposals include electing five directors, ratifying the appointment of Marcum LLP as the independent auditor for the fiscal year ending December 31, 2025, and approving a reverse stock split of the Common Stock at a ratio of not more than 1-for-150.
• Stockholders will also vote on approving the 2024 Employee Incentive Plan and the issuance of shares to an accredited investor under a common stock purchase agreement (ELOC Agreement).
• The Board of Directors recommends voting FOR all nominees and proposals.
• As of May 14, 2024, there were 103,468,373 shares of Common Stock outstanding.
• The company is seeking approval to issue up to $100 million in shares of Common Stock to an investor pursuant to the ELOC Agreement.

Sentiment

Score: 4

Explanation: The document presents a mixed sentiment. While there are positive aspects such as the potential for securing funding and incentivizing employees, the need for a reverse stock split and the risk of dilution indicate underlying challenges and uncertainties.

Positives

• The ELOC Agreement provides a potential reliable source of capital for the company, up to $100 million.
• The 2024 Employee Incentive Plan is designed to attract, retain, and motivate employees, directors, and consultants.
• The reverse stock split aims to increase the stock price to regain compliance with Nasdaq listing requirements.
• The company's Board of Directors is actively involved in risk management and corporate governance.

Negatives

• The company received a Nasdaq deficiency notice for not meeting the $1 minimum bid price requirement.
• The reverse stock split could potentially decrease the value of the company if the stock price does not increase proportionately.
• Issuance of shares under the ELOC Agreement will dilute existing stockholders' ownership and may result in a decline in stock price.
• The company may need to seek alternative sources of financing if Proposal No. 5 is not approved.

Risks

• Failure to regain compliance with Nasdaq listing requirements could result in delisting and reduced liquidity of the Common Stock.
• The reverse stock split may not achieve the desired increase in stock price.
• Dilution of existing stockholders' ownership due to potential issuance of shares under the ELOC Agreement.
• Dependence on stockholder approval for key proposals to secure financing and maintain listing status.

Future Outlook

The company aims to regain compliance with Nasdaq listing requirements through a reverse stock split and secure funding through the ELOC Agreement to implement its business plans.

Industry Context

Many institutional investors have policies prohibiting them from holding lower-priced stocks in their portfolios, which reduces the number of potential buyers of our Common Stock, although we have not been told by them that is the reason for not investing in our Common Stock. Additionally, analysts at many brokerage firms are reluctant to recommend lower-priced stocks to their clients or monitor the activity of lower-priced stocks. Brokerage houses frequently have internal practices and policies that discourage individual brokers from dealing in lower-priced stocks. Further, because brokers commissions on lower-priced stock generally represent a higher percentage of the stock price than commissions on higher priced stock, investors in lower-priced stocks pay transaction costs which are a higher percentage of their total share value, which may limit the willingness of individual investors and institutions to purchase our Common Stock.

Comparison to Industry Standards

• The document does not contain enough information to make a detailed comparison to industry standards.
• However, the need for a reverse stock split to maintain Nasdaq listing suggests the company's stock performance is lagging behind industry peers that maintain compliance without such measures.
• The ELOC agreement is a financing mechanism sometimes used by companies facing financial challenges, while more established companies often rely on traditional public offerings or debt financing.
• The document does not provide enough information to compare the company's executive compensation practices to industry benchmarks.

Related Party Transactions

• We have not engaged in any related party transactions in the last three years.

Stakeholder Impact

• Stockholders will be impacted by the potential reverse stock split and dilution from the ELOC Agreement.
• Employees will be impacted by the new incentive plan.
• The company's ability to secure funding and maintain its Nasdaq listing will impact its overall viability and future prospects.

Next Steps

• Stockholders to vote on the proposals at the Annual Meeting on June 14, 2024.
• Board of Directors to determine the ratio for the reverse stock split by December 31, 2024, if approved.
• Company to enter into the ELOC Agreement and potentially issue shares to the accredited investor, if approved.
• Company to monitor and maintain compliance with Nasdaq listing requirements.

Key Dates

Keywords

reverse stock split, employee incentive plan, ELOC agreement, proxy statement, annual meeting, stockholder approval, Nasdaq, common stock, directors, Marcum LLP